Gerber® Gentle Everyday Probiotic Drops

for babies to help support the developing immune system and overall gut health

Gerber_Gentle_Everyday_Probiotic_Drops

Probiotic B. lactis:

  • Contributes to a balanced microbiota*
  • Shown to support an increased level of bifidobacteria compared to infants not supplemented with B. lactis
  • May help increase levels of immunoglobulins such as secretory IgA*
  • Helps to support gut barrier function*
  • Contributes to a healthy digestive tract*
  • Studied in over 1000 infants and 50 clinical trials
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Gerber® Gentle Everyday Probiotic Drops

YOUR PATIENTS CAN RECEIVE A $5 SAVINGS§ + FREE SHIPPING by using promo code COMFORT at checkout – ONLY at TheGerberStore.com

§Restrictions may apply.

Studies

B. lactis helps balance the microbiota

Significant increase in bifidobacteria in stools after 1 month of B. lactis supplementation

Graph

Supplementing infants with B. lactis can increase the amount of bifidobacteria in their microbiota, especially in those born by C-section

Adapted from Yunianty, 20131

Study design: An observational study of 122 healthy, breastfed infants delivered vaginally or by C-section. Infants assigned to the test group received breast milk and formula supplemented with the B. lactis probiotics, whereas infants in the control group received breast milk and formula without probiotics. The presence of B. lactis and stool bifidobacteria counts were serum immune markers, and stool IgA was also assessed.

divider

B. lactis increased secretory IgA

B. lactis significantly increased vaccine-specific secretory IgA (sIgA) in infants delivered by C-sections

Graph

sIgA is an important antibody that helps to support the developing immune system

Adapted from Holscher, 20122

Study design: Six-week-old healthy, full-term infants (n=172) were enrolled in a prospective, randomized, double-blind, controlled clinical trial with 2 groups studied in parallel to a breastfed comparison group. Formula-fed infants were randomized to partially hydrolyzed whey formula or the same formula containing 106 CFU of B. lactis Bb12/g for 6 weeks. Fecal secretory IgA, calprotectin, lactate, and stool pH were assessed at baseline, 2 weeks, and 6 weeks. Anti-poliovirus-specific IgA and anti-rotavirus-specific IgA were assessed at 2 and 6 weeks.
sIgA, secretory immunoglobulin A: CFU, colony-forming unit

References 1. Yuniaty T, Kadi V, Sukandar H, et al. Impact of Bifidobacterium lactis supplementation on fecal microbiota in infants delivered vaginally compared to Caesarean section. Paediatr Indones. 2013;52:89-98. 2. Holscher HD, Tappenden KA. Bifidobacterium lactis Bb-12 enhances intestinal antibody response in formula-fed infants. J Parenter Enteral Nutr. 2012;36:106S-117S.
scroll to top